Biosensors Integration in Blood–Brain Barrier-on-a-Chip: Emerging Platform for Monitoring Neurodegenerative Diseases

[Image: see text] Over the most recent decades, the development of new biological platforms to study disease progression and drug efficacy has been of great interest due to the high increase in the rate of neurodegenerative diseases (NDDs). Therefore, blood–brain barrier (BBB) as an organ-on-a-chip...

Descripción completa

Detalles Bibliográficos
Autores principales: Mir, Mònica, Palma-Florez, Sujey, Lagunas, Anna, López-Martínez, Maria José, Samitier, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150172/
https://www.ncbi.nlm.nih.gov/pubmed/35559649
http://dx.doi.org/10.1021/acssensors.2c00333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150172/
https://www.ncbi.nlm.nih.gov/pubmed/35559649
http://dx.doi.org/10.1021/acssensors.2c00333

Ejemplares similares